The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 5 years ago 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings You may also like 11:20 PTC Therapeutics (Ataluren) 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 12:20 Catabasis 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 11:23 Antisense Therapeutics 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 13:19 PTC Therapeutics 5 years ago Approved Therapies,Conferences & Meetings 15:43 Sarepta Therapeutics 5 years ago Approved Therapies,Conferences & Meetings 7:48 What is a Post Market Study? 5 years ago Approved Therapies,Conferences & Meetings «1…2223242526…28»Page 24 of 28